JP2016508969A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508969A5
JP2016508969A5 JP2015548050A JP2015548050A JP2016508969A5 JP 2016508969 A5 JP2016508969 A5 JP 2016508969A5 JP 2015548050 A JP2015548050 A JP 2015548050A JP 2015548050 A JP2015548050 A JP 2015548050A JP 2016508969 A5 JP2016508969 A5 JP 2016508969A5
Authority
JP
Japan
Prior art keywords
compound
cancer
alkyl
patent document
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015548050A
Other languages
English (en)
Japanese (ja)
Other versions
JP6357292B2 (ja
JP2016508969A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/075505 external-priority patent/WO2014093988A2/en
Publication of JP2016508969A publication Critical patent/JP2016508969A/ja
Publication of JP2016508969A5 publication Critical patent/JP2016508969A5/ja
Application granted granted Critical
Publication of JP6357292B2 publication Critical patent/JP6357292B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015548050A 2012-12-14 2013-12-16 Cnksr1を阻害するための方法及び組成物 Active JP6357292B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261737658P 2012-12-14 2012-12-14
US61/737,658 2012-12-14
PCT/US2013/075505 WO2014093988A2 (en) 2012-12-14 2013-12-16 Methods and compositions for inhibiting cnksr1

Publications (3)

Publication Number Publication Date
JP2016508969A JP2016508969A (ja) 2016-03-24
JP2016508969A5 true JP2016508969A5 (cg-RX-API-DMAC7.html) 2017-02-23
JP6357292B2 JP6357292B2 (ja) 2018-07-11

Family

ID=50935099

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015548050A Active JP6357292B2 (ja) 2012-12-14 2013-12-16 Cnksr1を阻害するための方法及び組成物

Country Status (7)

Country Link
US (1) US9340532B2 (cg-RX-API-DMAC7.html)
EP (1) EP2931280B1 (cg-RX-API-DMAC7.html)
JP (1) JP6357292B2 (cg-RX-API-DMAC7.html)
AU (1) AU2013358876B2 (cg-RX-API-DMAC7.html)
CA (1) CA2895162C (cg-RX-API-DMAC7.html)
MX (2) MX372739B (cg-RX-API-DMAC7.html)
WO (1) WO2014093988A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6357292B2 (ja) 2012-12-14 2018-07-11 フューシス セラピューティクス、インク. Cnksr1を阻害するための方法及び組成物
CA2983260C (en) * 2015-04-20 2024-01-23 Phusis Therapeutics, Inc. Sulfonamide compounds, compositions and methods for inhibiting cnksr1
US20190367457A1 (en) 2016-12-30 2019-12-05 Mitobridge, Inc. Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors
CN110698411B (zh) * 2018-07-09 2023-05-09 四川大学 一类4-(胺烷基)酞嗪-1-酮类化合物、其制备方法和用途
EP4188383A4 (en) * 2020-07-28 2025-01-08 Mirati Therapeutics, Inc. SOS1 INHIBITORS
WO2022187804A1 (en) * 2021-03-02 2022-09-09 Icahn School Of Medicine At Mount Sinai Benzoxazolone inhibitors of inflammasomes
TW202319375A (zh) * 2021-08-19 2023-05-16 美商安進公司 用於製備丙烯酸酯化合物之無鈀方法
WO2024192873A1 (zh) * 2023-03-20 2024-09-26 杭州天玑济世生物科技有限公司 一类具有萘胺结构的小分子化合物的用途
CN116444477B (zh) * 2023-04-04 2026-01-02 宁波九胜创新医药科技有限公司 一种溴代胡椒环羧酸的制备方法及其用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA775563A (en) 1968-01-09 Frank W. Horner Limited Hypoglycemic thiadiazoles
GB828963A (en) 1956-08-03 1960-02-24 Rhone Poulenc Sa Pharmaceutical compositions containing 2-p-aminobenzenesulphonamido-5-t-butyl-1, 3, 4-thiadiazole
US3821222A (en) 1971-11-22 1974-06-28 Chevron Res Hydrocarbyl sulfenylmercapto pyrimidines
US4017489A (en) 1975-07-10 1977-04-12 The Goodyear Tire & Rubber Company Process of preparing unsymmetrical disulfides
DE2556011A1 (de) 1975-12-12 1977-06-23 Merck Patent Gmbh Disulfide
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
GB2152497B (en) 1983-11-28 1987-08-05 Otsuka Kagaku Kk Process for the preparation of azetidinone derivatives
FR2573077B1 (fr) 1984-11-13 1987-02-13 Sanofi Sa Nouveaux derives thiosulfonates, leur procede de preparation ainsi que les compositions pharmaceutiques les contenant
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4990523A (en) 1989-06-19 1991-02-05 A. H. Robins Company, Incorporated Treatment of chronic inflammatory joint disease with arylsulfonamides
GB9507415D0 (en) * 1994-06-08 1995-05-31 Zylepsis Ltd Production and uses of caffeic acid and derivatives thereof
US6139875A (en) 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
FR2815032B1 (fr) 2000-10-10 2003-08-08 Pf Medicament Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
JP2004527531A (ja) 2001-04-10 2004-09-09 メルク エンド カムパニー インコーポレーテッド 癌を治療する方法
KR100957516B1 (ko) * 2001-08-15 2010-05-14 이코스 코포레이션 2h-프탈라진-1-온 및 이것의 사용 방법
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
AU2003226301A1 (en) 2002-04-08 2003-10-20 Merck And Co., Inc. Method of treating cancer
GB0215823D0 (en) * 2002-07-09 2002-08-14 Astrazeneca Ab Quinazoline derivatives
US20040102360A1 (en) 2002-10-30 2004-05-27 Barnett Stanley F. Combination therapy
EP1644390B1 (en) 2003-06-24 2011-04-20 Isis Innovation Limited Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
CA2531418A1 (en) 2003-07-08 2005-01-20 Novartis Ag Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
EP1751225B1 (en) 2004-03-19 2009-08-05 The Tapemark Company Thermoplastic films and methods for making
JP2007530589A (ja) 2004-03-26 2007-11-01 アンフォラ ディスカバリー コーポレーション 特定のトリアゾールを基礎とする化合物、組成物、およびそれらの使用
SE0402635D0 (sv) 2004-10-29 2004-10-29 Astrazeneca Ab Chemical compounds
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone
DE602006018172D1 (de) 2005-10-06 2010-12-23 Sanofi Aventis Cyclische n-ä1,3,4ü-thiadiazol-2-yl-benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel
US20070213378A1 (en) 2006-03-10 2007-09-13 Lymphosign Inc. Compounds for modulating cell proliferation, compositions and methods related thereto
KR20150038395A (ko) 2006-04-04 2015-04-08 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 키나제 길항물질
EP2104489A2 (en) 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topical administration of danazol
EP2291349A2 (en) 2008-04-14 2011-03-09 The Board of Regents of The University of Texas System Small molecule inhibitors of the pleckstrin homology domain and methods for using same
WO2010085968A1 (en) * 2008-12-30 2010-08-05 European Molecular Biology Laboratory (Embl) Toluidine sulfonamides and their use as hif-inhibitors
JP5756457B2 (ja) * 2009-04-06 2015-07-29 アジオス ファーマシューティカルズ, インコーポレイテッド ピルビン酸キナーゼm2調節剤、治療組成物および関連する使用方法
US20120189670A1 (en) 2009-09-14 2012-07-26 Kirkpatrick D Lynn Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
CA2832100A1 (en) * 2011-04-05 2012-10-11 Vertex Pharmaceuticals Incorporated Aminopyrazine compounds useful as inhibitors of tra kinase
JP6357292B2 (ja) 2012-12-14 2018-07-11 フューシス セラピューティクス、インク. Cnksr1を阻害するための方法及び組成物

Similar Documents

Publication Publication Date Title
CN115768427B (zh) 癌症疗法中用于靶向降解不可靶向的kras的新型小分子
JP2016513661A5 (cg-RX-API-DMAC7.html)
WO2017040993A4 (en) Small molecule inhibitors of dyrk1a and uses thereof
JP2009541223A5 (cg-RX-API-DMAC7.html)
JP6835472B2 (ja) 癌の処置のための組成物
JP7319977B2 (ja) チューブリン阻害剤
TW202014186A (zh) 作為核轉運調節劑之化合物及其用途
MD3442972T2 (ro) Inhibitori ai bromodomeniului
AU2019366819B2 (en) Biomarkers of MetAP2 inhibitors and applications thereof
JP6357292B2 (ja) Cnksr1を阻害するための方法及び組成物
JP2024511996A5 (cg-RX-API-DMAC7.html)
KR20140035493A (ko) 중수소 농축된 4-하이드록시-5-메톡시-n,1-다이메틸-2-옥소-n-[(4-트리플루오로-메틸)페닐]-1,2-다이하이드로퀴놀린-3-카르복사미드
JP2014530243A (ja) Arry−380の多形体、選択的herb2阻害剤、およびそれらを含有する薬学的組成物
WO2021018032A1 (en) Pharmaceutical composition of mdm2 inhibitor and use thereof for preventing and/or treating disease
JP2015535247A5 (cg-RX-API-DMAC7.html)
Ozgur et al. Heat shock protein 90 inhibitors in oncology
JP2020528938A5 (cg-RX-API-DMAC7.html)
JP2019524738A (ja) ケモカインの生物活性を中和するためのピリミジノン誘導体およびその使用
EP3296294B1 (en) Compound for treating or preventing breast cancer
WO2007132221A1 (en) Combined anticancer pyrimidine-thiazole aurora kinase inhibitors
US10173995B2 (en) Pyridine compounds used as PI3 kinase inhibitors
WO2019241766A1 (en) Oligonucleotide-based proteolysis targeting chimera
JP7027324B2 (ja) 増殖性疾病の組み合せ療法
US9546159B2 (en) N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer
Kim et al. Synthesis and structure-activity relationship studies of 1, 5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 1 (JAK1) inhibitors